| Host: |
HEK293 cells |
| Reactivity: |
SARS-COV-2 |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Recombinant-SARS-COV-2 Spike S1+S2 ECD (S-ECD) (D614G) Trimer-C-His & Avi protein was developed from hek293 cells and has a target region of C-His & Avi. For use in research applications. |
| Formulation: |
Lyophilized from a 0.22 Mu m filtered solution of PBS, pH 7.4. |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Immunoreactivity: |
Immobilized SARS-COV-2 Spike S (D614G) Trimer, His Tag at 1 Mu g/mL (100 Mu L/Well) on the plate. Dose response curve for Human ACE2, Fc Tag with the EC50 of 0.1 Mu g/mL determined by ELISA. |
| Immunogen Region: |
Val16-Glu1188 |
| Immunogen: |
Recombinant SARS-COV-2 Spike S Trimer (D614G) Protein is produced by Expi293 expression system. The target protein is expressed with sequence (Val16-Glu1188 (D614G) ) of SARS-COV-2 Spike S Trimer (D614G) fused with a His tag and Avi at the C-terminal |
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
